Partner, Third Rock Ventures
CEO of Dynamis Corporation
Co-Founder, Sakti3
Medical College of Wisconsin director of research commercialization
Head of global research and development at Life Technologies
CEO of Project Foundry
Founding Director, Massachusetts Technology Transfer Center
Partner at New Enterprise Associates
Accelerators and apprenticeships, venture deals and partnerships. Here’s a roundup of Boston technology news bits from the week. Read on:
—Nonprofit tech accelerator MassChallenge is toying with launching a for-profit entity to help alumni of the program “further accelerate their... Read more »
Thanksgiving is around the corner and this week delivered a bounty of deals that have a number of life science companies expressing their thanks a little early.
One deal saw a company land a whopping $800 million upfront for a rights... Read more »
Shyft Technologies, a Seattle-based startup that has developed a software platform for retail and hospitality workers, and their employers, says it has raised $6.5 million in new funding to further develop its product.
Two venture capital firms based in the Seattle... Read more »
[Updated 5:20 p.m. See below.] Having to wait for a package to arrive generally doesn’t result in severe consequences, besides perhaps a feeling of frustration.
Some deliveries, however, are only useful if they arrive on time.
Logistics startup Airspace... Read more »
If you thought Siemens’ $730 million purchase of Boston-based business app developer Mendix would have locked the digital company’s focus onto the factory floor, CEO Derek Roos wants you to know you’re wrong.
The reality, Roos claims, is that the Mendix... Read more »
[Updated, 11/15/18, 2:06 p.m. ET. See below.] Arena Pharmaceuticals continued its comeback Thursday, netting a whopping $800 million up front in a deal that hands United Therapeutics another experimental drug for the rare blood disorder pulmonary arterial hypertension (PAH).... Read more »
As word trickled out that North Texas was likely one of three finalists for Amazon’s “HQ2,” Chris Wallace felt optimistic about the region’s prospects.
After all, the tech giant had said its priorities included a skilled workforce, logistics infrastructure, and a... Read more »
A growing number of startups are trying to encourage people to share genomic and other health data for research purposes by offering them some form of compensation. Now, as competition in this young sector ramps up, one of the big questions... Read more »
The race to treat hemophilia with gene therapy, a one-time, long-lasting infusion, is entering its final stages. And with new data released this morning, Dutch and Lexington, MA, firm UniQure has finalized its plans to be among the top finishers.
UniQure... Read more »
The shaking, tremors, and loss of muscle control in some movement disorders can be traced to misfiring neurons. Cadent Therapeutics has developed a drug intended to help those neurons send signals properly. The Cambridge, MA-based company now $40 million in Series... Read more »
Synthetic biology company Synthorx is laying plans for an initial public offering to raise money to advance its suite of enhanced cytokine drugs.
The San Diego-based company says it wants to use the proceeds to put its lead product candidate, an... Read more »
Celgene’s collaboration with Dragonfly Therapeutics is less than 18 months old, but the pharmaceutical company is already expanding the alliance.
Celgene (NASDAQ: CELG) is paying Waltham, MA-based Dragonfly $50 million upfront to add four more drug targets to the four... Read more »
Bain Capital Ventures has raised $1 billion to pour into technology companies large and small across a swath of industries, the largest single round of fundraising in the firm’s history.
The cash includes a $650 million core fund—that’ll be aimed half... Read more »
The wait is finally over.
Amazon said Tuesday it plans to significantly expand its presence in the New York City and Washington, DC, metropolitan areas beginning next year. The announcement was widely expected following news reports identifying the locales as likely... Read more »
Let’s catch up on the latest innovation news in Texas.
—Coder, a cloud-based software development startup out of Austin, announced it has raised $4.5 million in seed funding. The round was led by Uncork Capital and Redpoint Ventures, with... Read more »
The transformation of Johnson Controls International continues.
On Tuesday, the company said it reached a deal to sell its power solutions business, which makes a variety of vehicle batteries, in a cash transaction valued at $13.2 billion. The buyers are investment... Read more »
GreatCall, the maker of the Jitterbug cellphone and other products and services for older adults, has extended its partnership with the San Francisco-based ride-hailing company Lyft to offer GreatCall customers the ability to schedule rides without a smartphone app. No financial... Read more »
[Updated 11/13/18, 12:05 pm, with executive comments throughout.] The data storage wars rage on.
Boston-based primary data storage and backup provider ClearSky Data has raised $20 million in new funding to bring more customers aboard its “on-demand” hybrid cloud... Read more »
Cells have a built-in way of breaking down damaged or unneeded proteins. Kymera Therapeutics is trying to harness this process as a therapy—using it to get rid of disease-causing proteins. As the biotech prepares to test its technology in humans, it... Read more »
Most drugs target proteins in the cell, but the world of RNA has remained largely untapped by companies making chemical-based, or small-molecule drugs. That’s changing though—just in the last couple of years, there’s been a mini-boom in biotechs trying to overturn... Read more »
A little more than a month after Rethink Robotics shut down, a competitor has hired more than 20 of the Boston-based firm’s former employees.
Universal Robots, a Denmark-based maker of collaborative industrial robots, announced Tuesday it has brought on key... Read more »
Houston—Commercial drones are equipped with some of the latest innovations in cameras, sensors, and analytics, so Scott Parazynski wondered why pilots are still using outmoded controllers.
“We’ve grown accustomed to these tools but decades later it’s the same [controller] model,”... Read more »
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
CEO and Fund Manager, Renaissance Venture Capital Fund
VP of Research & Policy, Ewing Marion Kauffman Foundation
Head of global research and development at Life Technologies
Managing Director, Mercury Fund
CEO, Next Great Place
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
